In the BioHarmony Drug Report Database

"Preview" Icon

Cimetidine

Tagamet, Tagamet Hb (cimetidine) is a small molecule pharmaceutical. Cimetidine was first approved as Tagamet on 1982-01-01. It is used to treat duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. The pharmaceutical is active against histamine H2 receptor. In addition, it is known to target multidrug and toxin extrusion protein 2, multidrug and toxin extrusion protein 1, and equilibrative nucleoside transporter 4.

 

Trade Name

 

Tagamet, Tagamet Hb
 

Common Name

 

cimetidine
 

ChEMBL ID

 

CHEMBL30
 

Indication

 

duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, helicobacter infections, peptic esophagitis, stomach ulcer, urticaria, zollinger-ellison syndrome
 

Drug Class

 

H2-receptor antagonists (cimetidine type)

Image (chem structure or protein)

Cimetidine structure rendering